<DOC>
	<DOCNO>NCT00275197</DOCNO>
	<brief_summary>The major purpose study help determine whether give combination Elzasonan Zoloft people depression well treatment take Zoloft alone . This study also compare safety tolerability Elzasonan Zoloft combination Zoloft alone placebo .</brief_summary>
	<brief_title>A Research Study Compare Treatments Combination Elzasonan With Zoloft , Zoloft Alone , Placebo People With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Adult subject , 18 year age old diagnosis recurrent , moderatetosevere MDD without psychotic feature ( DSMIV 296.3x , HAMD17 score &gt; = 22 CGIS &gt; =4 . MDD must primary psychiatric disorder motivate subject seek treatment current episode must least 1 month duration longer 6 month duration . Subjects , investigator 's judgement , would require treatment electroconvulsive therapy ( ECT ) , antipsychotic , would require change intensity psychotherapy , subject would require treatment psychotherapeutic drug course trial . Subjects ever diagnose Panic Disorder , PostTraumatic Stress Disorder , ObsessiveCompulsive Disorder , Bipolar Affective Disorder , Schizophrenia , Schizoaffective Disorder othe Psychotic Disorder , MDD seasonal pattern , Dissociative Disorders per DSMIV criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>